KIROMIC Trademark

Trademark Overview


On Thursday, June 30, 2022, a trademark application was filed for KIROMIC with the United States Patent and Trademark Office. The USPTO has given the KIROMIC trademark a serial number of 97484081. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, December 12, 2023. This trademark is owned by Kiromic Biopharma, Inc.. The KIROMIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
kiromic

General Information


Serial Number97484081
Word MarkKIROMIC
Filing DateThursday, June 30, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, December 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Description of MarkThe mark consists of the word KIROMIC and the letter O of the word represents a sun.
Goods and ServicesPharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKiromic Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Party NameKiromic Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events


Event DateEvent Description
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 12, 2023SOU EXTENSION 2 FILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 8, 2023SOU EXTENSION 1 GRANTED
Saturday, July 8, 2023SOU EXTENSION 1 FILED
Saturday, July 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 5, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 5, 2022NON-FINAL ACTION WRITTEN
Monday, October 3, 2022ASSIGNED TO EXAMINER
Thursday, July 21, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 4, 2022NEW APPLICATION ENTERED